Mast cells and hemangioma

Area of Science:

• Vascular Biology
• Tumor Microenvironment
• Cellular Pathology

Background:

• Hemangioma is a benign vascular tumor characterized by excessive angiogenesis followed by spontaneous regression.
• Mast cells are implicated in hemangioma pathophysiology, exhibiting heterogeneity in phenotype and function.
• Type VIII collagen is detected, potentially playing a role in endothelial cell migration and extracellular matrix deposition.

Purpose of the Study:

• To investigate the dynamic role of mast cells throughout the developmental phases of hemangioma.
• To analyze mast cell phenotypes, including tryptase and chymase expression, in relation to hemangioma involution.
• To explore the involvement of type VIII collagen and clusterin/apolipoprotein J in hemangioma development and regression.

Main Methods:

• Analysis of hemangioma biopsy specimens across proliferative, involuting, and involuted phases.
• Utilized Csaba stain to identify mast cell phenotypes (biogenic amine, tryptase, chymase).
• Assessed expression of type VIII collagen and clusterin/apolipoprotein J.

Main Results:

• Mast cell numbers increase during involution, with a decreasing proportion expressing both tryptase and chymase.
• Type VIII collagen is present throughout development, with intracellular localization in mast cells during the proliferative phase.
• Increased clusterin/apolipoprotein J expression in mast cells correlates with involution, suggesting a role in apoptosis and regression.

Conclusions:

• Mast cells exhibit dual roles in hemangioma: potentially stimulating angiogenesis in early phases and promoting regression in later stages.
• The changing proportion of mast cell phenotypes and expression of clusterin/apolipoprotein J suggest a significant role in tumor involution.
• Mast cells may contribute to hemangioma regression by secreting apoptotic modulators like clusterin/apolipoprotein J.